Clinical Trial Update: A Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial compares Rituximab/Bendamustine alternating therapy with Rituximab/Bendamustine/Cytarabine therapy versus RB alone in elderly patients with Mant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• CYTARABINE (CYTARABINE)
• Rituximab (rituximab)

Snippet

Sponsor: Kim, Seok Jin | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: RECRUITING